Published Online: September 15, 2016. doi:10.1001/jama.2016.11708
Concept and design: Bergenstal, Garg, Bode, Kaufman.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Bergenstal, Garg, Kaufman.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Kaufman.
Obtaining funding: Kaufman.
Administrative, technical, or material support: Bergenstal, Garg, Kaufman.
Study supervision: Bergenstal, Garg, Weinzimer, Buckingham, Bode.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bergenstal reports receiving grant funding and consulting and advisory board fees paid to his institution from Abbott Diabetes Care, Calibra, Eli Lilly, Hygieia, Johnson & Johnson, Medtronic, Novo Nordisk, Roche, and Sanofi; grant funding and consulting fees paid to his institution from Becton Dickinson, Boehringer Ingelheim, Bristol-Myers Squibb/Astrazeneca, and ResMed; grant funding from and holding stock in Merck; and grant funding and advisory board fees paid to his institution from Takeda. Dr Garg reports receiving grants, personal fees, and other from Eli Lilly and Sanofi; grants and personal fees from Medtronic and Novo-Nordisk; grants and other from Dexcom; grants from Lexicon, Jaeb Center For Health Research, Merck; and personal fees and other from Johnson & Johnson. Dr Weinzimer reports grants from Medtronic; grants and personal fees from Medtronic, personal fees from Insulet, Tandem, and Animas. Dr Buckingham reports participating in studies sponsored by Medtronic; receiving funding from Medtronic for principal investigator–initiated studies; consulting on the medical advisory board for Medtronic Minimed, Sanofi, Tandem, Novo-Nordisk; and receiving grants from Dexcom and Medtronic Diabetes. Dr Bode reports grants, honoraria, and personal fees for consulting from Medtronic. Dr Tamborlane reports personal fees from Medtronic Diabetes. Dr Kaufman participated in data analysis and was an employee of Medtronic at the time of this study. Drs Bergenstal, Garg, Weinzimer, Buckingham, Bode, and Tamborlane received compensation and research support for conducting the study from Medtronic.
Funding/Support: This study was funded by Medtronic.
Role of the Funder/Sponsor: Medtronic was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript. Medtronic was not involved in the decision to submit the manuscript for publication.
Additional Contributions: We thank the study participants and research coordinators; Thomas Troub, MS, and Cathy Rogert, RN (both Medtronic employees), for study monitoring; and the additional Medtronic study team for their contributions to the study operations. Contributors did not receive additional compensation besides their salaries from their institution. The following investigators of this study received compensation and research support for conducting the study from Medtronic: Timothy S. Bailey, MD; Ronald L. Brazg, MD; Jacob Ilany, MD; Trang Thao Ly, MBBS; Robert H. Slover, MD; and Stacey M. Anderson, MD. Benjamin Grosman, PhD; Anirban Roy, PhD; John B. Welsh, MD; John Shin, PhD; and Scott W. Lee, MD, participated in data analysis and are (or were) employees of Medtronic at the time of this study.